Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinoma.

Banerjee R, Henson BS, Russo N, Tsodikov A, D'Silva NJ.

Cell Signal. 2011 Jul;23(7):1110-8. doi: 10.1016/j.cellsig.2011.02.002. Epub 2011 Feb 21.

2.

Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells.

Uehara T, Kanazawa T, Mizukami H, Uchibori R, Tsukahara T, Urabe M, Kume A, Misawa K, Carey TE, Suzuki M, Ichimura K, Ozawa K.

Cancer Sci. 2014 Jan;105(1):72-80. doi: 10.1111/cas.12315. Epub 2013 Dec 1.

3.

The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer.

Banerjee R, Van Tubergen EA, Scanlon CS, Vander Broek R, Lints JP, Liu M, Russo N, Inglehart RC, Wang Y, Polverini PJ, Kirkwood KL, D'Silva NJ.

Mol Cancer Ther. 2014 May;13(5):1323-33. doi: 10.1158/1535-7163.MCT-13-0904. Epub 2014 Feb 25.

4.

Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells.

Kanazawa T, Kommareddi PK, Iwashita T, Kumar B, Misawa K, Misawa Y, Jang I, Nair TS, Iino Y, Carey TE.

Clin Cancer Res. 2009 Apr 1;15(7):2222-30. doi: 10.1158/1078-0432.CCR-08-2443. Epub 2009 Mar 10.

5.

Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.

Misawa Y, Misawa K, Kanazawa T, Uehara T, Endo S, Mochizuki D, Yamatodani T, Carey TE, Mineta H.

Cancer. 2014 Jan 15;120(2):205-13. doi: 10.1002/cncr.28411. Epub 2013 Oct 10.

6.

Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage.

Elliott-Hunt CR, Pope RJ, Vanderplank P, Wynick D.

J Neurochem. 2007 Feb;100(3):780-9.

7.

Galanin receptor 2 utilizes distinct signaling pathways to suppress cell proliferation and induce apoptosis in HNSCC.

Kanazawa T, Misawa K, Misawa Y, Maruta M, Uehara T, Kawada K, Nagatomo T, Ichimura K.

Mol Med Rep. 2014 Sep;10(3):1289-94. doi: 10.3892/mmr.2014.2362. Epub 2014 Jul 4.

PMID:
25017118
8.

Rap1 and its regulatory proteins: the tumor suppressor, oncogene, tumor suppressor gene axis in head and neck cancer.

Banerjee R, Russo N, Liu M, Van Tubergen E, D'Silva NJ.

Small GTPases. 2012 Jul-Sep;3(3):192-7. doi: 10.4161/sgtp.20413. Epub 2012 Jun 11.

9.

Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2).

Tofighi R, Joseph B, Xia S, Xu ZQ, Hamberger B, Hökfelt T, Ceccatelli S.

Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2717-22. doi: 10.1073/pnas.0712300105. Epub 2008 Feb 12.

10.

Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck.

Lango MN, Dyer KF, Lui VW, Gooding WE, Gubish C, Siegfried JM, Grandis JR.

J Natl Cancer Inst. 2002 Mar 6;94(5):375-83.

PMID:
11880476
11.

Galanin receptor 1 has anti-proliferative effects in oral squamous cell carcinoma.

Henson BS, Neubig RR, Jang I, Ogawa T, Zhang Z, Carey TE, D'Silva NJ.

J Biol Chem. 2005 Jun 17;280(24):22564-71. Epub 2005 Mar 14.

12.

Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells.

Jameson MJ, Beckler AD, Taniguchi LE, Allak A, Vanwagner LB, Lee NG, Thomsen WC, Hubbard MA, Thomas CY.

Mol Cancer Ther. 2011 Nov;10(11):2124-34. doi: 10.1158/1535-7163.MCT-11-0294. Epub 2011 Aug 30.

13.

Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cells.

Lin YC, Wu MH, Wei TT, Chuang SH, Chen KF, Cheng AL, Chen CC.

Neoplasia. 2012 Jun;14(6):463-75.

14.
15.

Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.

Cohen EE, Lingen MW, Zhu B, Zhu H, Straza MW, Pierce C, Martin LE, Rosner MR.

Cancer Res. 2006 Jun 15;66(12):6296-303.

16.

Metadherin regulation of vascular endothelial growth factor expression is dependent upon the PI3K/Akt pathway in squamous cell carcinoma of the head and neck.

Zhu GC, Yu CY, She L, Tan HL, Li G, Ren SL, Su ZW, Wei M, Huang DH, Tian YQ, Su RN, Liu Y, Zhang X.

Medicine (Baltimore). 2015 Feb;94(6):e502. doi: 10.1097/MD.0000000000000502.

17.

Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma.

Kanazawa T, Misawa K, Carey TE.

Expert Opin Ther Targets. 2010 Mar;14(3):289-302. doi: 10.1517/14728221003598922. Review.

PMID:
20148716
18.

HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma.

Lai JP, Chien J, Strome SE, Staub J, Montoya DP, Greene EL, Smith DI, Roberts LR, Shridhar V.

Oncogene. 2004 Feb 19;23(7):1439-47.

PMID:
14973553
19.

TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression.

Duvvuri U, Shiwarski DJ, Xiao D, Bertrand C, Huang X, Edinger RS, Rock JR, Harfe BD, Henson BJ, Kunzelmann K, Schreiber R, Seethala RS, Egloff AM, Chen X, Lui VW, Grandis JR, Gollin SM.

Cancer Res. 2012 Jul 1;72(13):3270-81. doi: 10.1158/0008-5472.CAN-12-0475-T. Epub 2012 May 7.

20.

BCR/ABL and IL-3 activate Rap1 to stimulate the B-Raf/MEK/Erk and Akt signaling pathways and to regulate proliferation, apoptosis, and adhesion.

Jin A, Kurosu T, Tsuji K, Mizuchi D, Arai A, Fujita H, Hattori M, Minato N, Miura O.

Oncogene. 2006 Jul 20;25(31):4332-40. Epub 2006 Mar 6.

PMID:
16518411

Supplemental Content

Support Center